120426-39-3

Upstream product

• 115909-91-6 1-(Benzyloxycarbonyl)-4-(2-hydroxyethyl)piperidine 

Downstream Products

• 461052-27-7 4-[2-(3-formyl-indol-1-yl)-ethyl]-piperidine-1-carboxylic acid benzyl ester 
• 461052-23-3 1-[2-(1-benzyloxycarbonyl-piperidin-4-yl)-ethyl]-1H-indole-3-carboxylic acid methyl ester 
• 461052-25-5 4-[2-(3-methoxycarbonylmethyl-indol-1-yl)-ethyl]-piperidine-1-carboxylic acid benzyl ester 
• 461052-32-4 1-[2-(1-benzyloxycarbonyl-piperidin-4-yl)-ethyl]-1H-indole-3-carboxylic acid 
• 461052-33-5 4-[2-(3-carboxymethyl-indol-1-yl)-ethyl]-piperidine-1-carboxylic acid benzyl ester 
• 461052-35-7 4-{2-[3-((E)-2-Carboxy-vinyl)-indol-1-yl]-ethyl}-piperidine-1-carboxylic acid benzyl ester 
• 461052-29-9 benzyl 4-(2-{3-[(E)-3-ethoxy-3-oxo-1-propenyl]-1H-1-indolyl}-ethyl)-1-piperidinecarboxylate 
• 461052-37-9 4-{2-[3-((E)-2-Carboxy-propenyl)-indol-1-yl]-ethyl}-piperidine-1-carboxylic acid benzyl ester 
• 461052-31-3 benzyl 4-(2-{3-[(E)-3-ethoxy-2-methyl-3-oxo-1-propenyl]-1H-1-indolyl}-ethyl)-1-piperidinecarboxylate 
• 461052-38-0 4-{2-[3-(2-ethoxycarbonyl-ethylcarbamoyl)-indol-1-yl]-ethyl}-piperidine-1-carboxylic acid benzyl ester 
• 461052-43-7 4-(2-{3-[(E)-2-(2-Methoxycarbonyl-1-methyl-ethylcarbamoyl)-vinyl]-indol-1-yl}-ethyl)-piperidine-1-carboxylic acid benzyl ester 
• 461052-39-1 4-(2-{3-[(2-ethoxycarbonyl-ethylcarbamoyl)-methyl]-indol-1-yl}-ethyl)-piperidine-1-carboxylic acid benzyl ester 
• 461052-41-5 4-(2-{3-[(E)-2-(2-Ethoxycarbonyl-ethylcarbamoyl)-vinyl]-indol-1-yl}-ethyl)-piperidine-1-carboxylic acid benzyl ester 
• 461052-45-9 4-(2-{3-[(E)-2-(2-Ethoxycarbonyl-ethylcarbamoyl)-propenyl]-indol-1-yl}-ethyl)-piperidine-1-carboxylic acid benzyl ester 

Relevant academic research and scientific papers

Design and synthesis of a series of indole glycoprotein IIb/IIIa inhibitors

Synthesis of 1,3-disubstituted indoles derivatives as potential glycoprotein (GP) IIb/IIIa antagonists was reported. Substitution of the indolic nitrogen atom by piperidino or benzamidino moieties was used as mimics of an arginine residue. The acid carboxylic group was linked to the indole scaffold in position-3 via a methylene unit (compounds 4, 9, 10). Introduction of a β-alanine chain was carried out on the acids (17-22) which after deprotection and basic hydrolysis afforded the final compounds 39-46. The distance between the indole scaffold and the amide bond was modulated from no methylene unit (compound 39) to 1 (compounds 40, 41) or 2 methylene units (compounds 42-46). The presence of a tosylamino group on the β-alanine chain (compound 56) slightly increased the inhibiting action on platelet aggregation initiated by collagen.

Fibrinogen receptor antagonists

Compounds of the invention have the formula STR1 The compounds have fibrinogen receptor antagonist activity.